Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MDMA-assisted Massed Prolonged Exposure for PTSD

NCT06117306 is registered in ClinicalTrials.gov with Healing Breakthrough as lead sponsor.

NCT NCT06117306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06117306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MDMA-assisted Massed Prolonged Exposure for PTSD
Lead sponsor
Healing Breakthrough
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 25, 2024
Completion date
March 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder